repaglinide
Selected indexed studies
- Repaglinide. (Drugs Aging, 1998) [PMID:9739505]
- Repaglinide: prandial glucose regulation in clinical practice. (Diabetes Obes Metab, 2000) [PMID:11225759]
- Repaglinide--prandial glucose regulator: a new class of oral antidiabetic drugs. (Diabet Med, 1998) [PMID:9868989]
_Worker-drafted node — pending editorial review._
Connections
repaglinide is a side effect of
Sources
- Repaglinide. (1998) pubmed
- Repaglinide: prandial glucose regulation in clinical practice. (2000) pubmed
- Repaglinide--prandial glucose regulator: a new class of oral antidiabetic drugs. (1998) pubmed
- Repaglinide: a review of its use in type 2 diabetes mellitus. (2012) pubmed
- Repaglinide, a new oral antidiabetic agent: a review of recent preclinical studies. (1999) pubmed
- Repaglinide as monotherapy in Type 2 diabetes. (1999) pubmed
- Repaglinide: a review of its therapeutic use in type 2 diabetes mellitus. (2001) pubmed
- [Repaglinide (NN-623)]. (2002) pubmed
- [Repaglinide (NN-623)]. (1997) pubmed
- Clinical pharmacokinetics and pharmacodynamics of repaglinide. (2002) pubmed